Palbociclib 125mg tablets
NHS hospitals in England used £56,998,214 of indicative cost of Palbociclib 125mg tablets in the 12 months to April 2026, about 0.2% of all hospital medicines spend. That is down 14.5% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Palbociclib 125mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Palbociclib 125mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Clatterbridge Cancer Centre Nhs Ft | £2,796,600 |
| The Royal Marsden Nhs Foundation Trust | £1,924,803 |
| The Christie Nhs Foundation Trust | £1,584,010 |
| East And North Hertfordshire Nhs Trust | £1,510,400 |
| Southend Univ Hosp Nhs Foundation Trust | £1,507,450 |
| Worcestershire Acute Hpls Nhs Trust | £1,469,100 |
| East Kent Hospitals University Nhs Ft | £1,371,750 |
| Royal Surrey County Hosp Nhs Found Trust | £1,277,350 |
| Univ Hpls Bristol Nhs Foundation Trust | £1,221,300 |
| Barts Health Nhs Trust | £1,215,400 |
The primary-care picture
Palbociclib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Palbociclib medicine page.